The abuse, misuse, and dependency of opioids continue to represent a significant problem in the U.S. Every day, approximately 44 people die from opioid overdose, and those who are addicted to opioids are 40 times more likely to also develop a heroin addiction, according to the CDC. The FDA is seeking to address this epidemic by reviewing their policies, particularly around pediatric opioid labeling.
The FDA recently approved OxyContin for use in children 11 years of age and older. While this gives physicians additional options in chronic pain management, it may also provide additional opportunities for teens who wish to experiment with pain medication. Parents should maintain possession of the drugs to prevent misuse, and should not adjust their child’s dosage without consulting their doctor.
Learn more about the FDA’s intended steps to combat opioid abuse at http://www.aappublications.org/news/2016/02/05/Opioids020516